It is really exciting to secure the funding needed to realise our vision. Over the past years, we have done so much market validation and technology development to prove that we have a winner in our hands.
Our solution improves upon the state-of-the-art by an order of magnitude on all important performance metrics (throughput, ease-of-use, level of detail), while dramatically reducing costs for the customer.
We are preparing to launch a fully automated microscope platform that can autonomously identify cells in tissue samples, streamlining the drug development process.
Typical testing for new compounds is complex and time-consuming, often taking months, but our solution reduces this analysis time to under a week.
Collection
[
|
...
]